Related Experiment Videos
Two waves of memory B-cell generation in the primary immune response
Ayako Inamine1, Yoshimasa Takahashi, Nobue Baba
1Department of Immunology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
International Immunology
|April 13, 2005
Summary
Memory B cells develop through two pathways: one involving germinal center (GC) reactions and affinity maturation, and another independent of these processes. This study reveals the GC-independent pathway generates low-affinity memory B cells.
Area of Science:
- Immunology
- Cell Biology
Background:
- Memory B cells are crucial for long-term immunity.
- Germinal center (GC) formation and affinity maturation are known pathways for memory B cell generation.
- The role of GC-independent pathways in normal mice is not well understood.
Purpose of the Study:
- To investigate the contribution of GC-independent memory B cell generation in normal mice.
- To determine if manipulating GC formation affects memory B cell development and antibody production.
Main Methods:
- Administration of anti-inducible co-stimulator (ICOS) monoclonal antibodies (mAbs) during the primary immune response in mice.
- Analysis of GC B cell generation, somatic mutation accumulation in IgV(H) genes, and affinity maturation.
- Assessment of memory B cell generation, antibody production, and secondary response reconstitution.
Main Results:
- Anti-ICOS treatment inhibited GC B cell generation but did not affect IgG1 memory B cells or long-term IgG1 antibody production.
- GC B cells in treated mice showed somatic mutations and affinity maturation.
- Memory B cells accumulated few mutations and mediated a low-affinity secondary response, indicating GC-independent generation.
Conclusions:
- Memory B cells are generated via two distinct pathways: one involving GC reactions and affinity maturation, and another independent of these processes.
- The GC-independent pathway generates low-affinity memory B cells.
- Low-affinity memory B cells can contribute to long-term antibody production and sustained immunity.